Mast cells in viral infections;Komórki tuczne w infekcjach wirusowych

Postepy Higieny i Medycyny Doswiadczalnej

Volumn 66, Issue , 2012, Pages 231-241

  Witczak, Piotr ^a   Brzezińska Błaszczyk, Ewa ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

Author keywords

Mast cells; Toll like receptors (TLRs); Viral infections; Viruses

Indexed keywords

EID: 84867945951     PISSN: 00325449     EISSN: 17322693     Source Type: Journal    
DOI: 10.5604/17322693.991610     Document Type: Review

References (98)

1. Abraham S. N., St. John A. L.: Mast cell-orchestrated immunity to pathogens. Nat. Rev. Immunol., 2010;10:440-452
2. Aravalli R. N., Hu S., Rowen T. N., Palmquist J. M., Lokensgard J. R.: Cutting edge: TLR2-mediated proinflammatory cytokine and chemokine production by microglial cells in response to herpes simplex virus. J. Immunol., 2005;175:4189-4193
3. Bannert N., Farzan M., Friend D. S., Ochi H., Price K. S., Sodroski J., Boyce J. A.: Human mast cell progenitors can be infected by macrophagetropic human immunodeficiency virus type 1 and retain virus with maturation in vitro. J. Virol., 2001;75:10808-10814
4. Bauernfeind F., Ablasser A., Bartok E., Kim S., Schmid-Burgk J., Cavlar T., Hornung V.: Inflammasomes: current understanding and open questions. Cell. Mol. Life Sci., 2010;68:765-783
5. Boehme K. W., Guerrero M., Compton T.: Human cytomegalovirus envelope glycoproteins B and H are necessary for TLR2 activation in permissive cells. J. Immunol., 2006;177:7094-7102
6. Brown M. G., Hermann L. L., Issekutz A. C., Marshall J. S., Rowter D., Al-Afif A., Anderson R.: Dengue virus infection of mast cells triggers endothelial cell activation. J. Virol., 2001;85:1145-1150
7. Brown M. G., Huang Y. Y., Marshall J. S., King C. A., Hoskin D. W., Anderson R.: Dramatic caspase-dependent apoptosis in antibody-enhanced dengue virus infection of human mast cells. J. Leukoc. Biol., 2009;85:71-80
8. Brown M. G., King C. A., Sherren C., Marshall J. S., Anderson R.: A dominant role for FcγRII in antibody-enhanced dengue virus infection of human mast cells and associated CCL5 release. J. Leukoc. Biol., 2006;80:1242-1250
9. Brzezińska-Błaszczyk E., Rdzany R. S.: The role of mast cells in innate immunity in antibacterial defense. Postȩpy Hig. Med. Dośw., 2005;59:544-553
10. Burke S. M., Issekutz T. B., Mohan K., Lee P. W., Shmulevitz M., Marshall J. S.: Human mast cell activation with virus-associated stimuli leads to the selective chemotaxis of natural killer cells by a CXCL8-dependent mechanism. Blood, 2008;111:5467-5476
11. Burzyn D., Rassa J. C., Kim D., Nepomnaschy I., Ross S. R., Piazzon I.: Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J. Virol., 2004;78:576-584
12. Busse W. W., Gern J. E.: Viruses in asthma. J. Allergy Clin. Immunol., 1997;100:147-150
13. Busse W. W., Lemanske R. F. Jr, Gern J. E.: Role of viral respiratory infections in asthma and asthma exacerbations. Lancet, 2010;376:826-834
14. Castleman W. L., Owens S. B., Brundage-Anguish L. J.: Acute and persistent alterations in pulmonary inflammatory cells and airway mast cells induced by Sendai virus infection in neonatal rats. Vet. Pathol., 1989;26:18-25
15. Castleman W. L., Sorkness R. L., Lemanske R. F. Jr, McAllister P. K.: Viral bronchiolitis during early life induces increased numbers of bronchiolar mast cells and airway hyperresponsiveness. Am. J. Pathol., 1990;137:821-831
16. Choe H., Farzan M., Sun Y., Sullivan N., Rollins B., Ponath P. D., Wu L., Mackay C. R., La Rosa G., Newman W., Gerard N., Gerard C., Sodroski J.: The β-chemokine receptors CCR3 and CCR5 facilitate infection by primary HIV-1 isolates. Cell, 1996;85:1135-1148
17. Dakhama A., Park J. W., Taube C., Chayama K., Balhorn A., Joetham A., Wei X. D., Fan R. H., Swasey C., Miyahara N., Kodama T., Alvarez A., Takeda K., Gelfand E. W.: The role of virus-specific immunoglobulin E in airway hyperresponsiveness. Am. J. Respir. Crit. Care Med., 2004;170:952-959
18. + cells. J. Immunol., 2000;165:7171-7179
19. Dietrich N., Rohde M., Geffers R., Kröger A., Hauser H., Weiss S., Gekara N. O.: Mast cells elicit proinflammatory but not type I interferon responses upon activation of TLRs by bacteria. Proc. Natl. Acad. Sci. USA, 2010;107:8748-8753
20. Dolganiuc A., Oak S., Kodys K., Golenbock D. T., Finberg R. W., Kurt-Jones E., Szabo G.: Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation. Gastroenterology, 2004;127:1513-1524
21. Domagalski K., Tretyn A., Pawłowska M., Szczepanek J., Halota W.: Działanie interferonów typu III i ich rola w odpowiedziach immunologicznych. Postȩpy Hig. Med. Dośw., 2010;64:522-533
22. Dulek D. E., Peebles R. S. Jr: Viruses and asthma. Biochim. Biophys. Acta, 2011;11:1080-1090
23. Everard M. L., Fox G., Walls A. F., Quint D., Fifield R., Walters C., Swarbrick A., Milner A. D.: Tryptase and IgE concentrations in the respiratory tract of infants with acute bronchiolitis. Arch. Dis. Child., 1995;72:64-69
24. Feng B. S., He S. H., Zheng P. Y., Wu L., Yang P. C.: Mast cells play a crucial role in Staphylococcus aureus peptidoglycan-induced diarrhea. Am. J. Pathol., 2007;171:537-547
25. Franceschini B., Russo C., Dioguardi N., Grizzi F.: Increased liver mast cell recruitment in patients with chronic C virus-related hepatitis and histologically documented steatosis. J. Viral. Hepat., 2007;14:549-555
26. Galli S. J., Grimbaldeston M., Tsai M.: Immunomodulatory mast cells: negative, as well as positive, regulators of immunity. Nat. Rev. Immunol., 2008;8:478-486
27. Galli S. J., Kalesnikoff J., Grimbaldeston M. A., Piliponsky A. M., Williams C. M., Tsai M.: Mast cells as "tunable" effector and immunoregulatory cells: recent advances. Annu. Rev. Immunol., 2005;23:749-786
28. Gavrilovskaya I. N., Shepley M., Shaw R., Ginsberg M. H., Mackow E. R.: β3 integrins mediate the cellular entry of hantaviruses that cause respiratory failure. Proc. Natl. Acad. Sci. USA, 1998;95:7074-7079
29. Genovese A., Borgia G., Bouvet J. P., Detoraki A., de Paulis A., Piazza M., Marone G.: Protein Fv produced during viral hepatitis is an endogenous immunoglobulin superantigen activating human heart mast cells. Int. Arch. Allergy Immunol., 2003;132:336-345
30. Ghorpade A., Xia M. Q., Hyman B. T., Persidsky Y., Nukuna A., Bock P., Che M., Limoges J., Gendelman H. E., Mackay C. R.: Role of the β-chemokine receptors CCR3 and CCR5 in human immunodeficiency virus type 1 infection of monocytes and microglia. J. Virol., 1998;72:3351-3361
31. Gibbons A. E., Price P., Robertson T. A., Papadimitriou J. M., Shellam G. R.: Replication of murine cytomegalovirus in mast cells. Arch. Virol., 1990;115:299-307
32. Gieryńska M., Schollenberger A.: Molekularne rozpoznawanie zakażeń wirusowych - stymulacja odpowiedzi immunologicznej. Postȩpy Hig. Med. Dośw., 2011;65:299-313
33. Guhl S., Franke R., Schielke A., Johne R., Krüger D. H., Babina M., Rang A.: Infection of in vivo differentiated human mast cells with hantaviruses. J. Gen. Virol., 2010;91:1256-1261
34. He J., Chen Y., Farzan M., Choe H., Ohagen A., Gartner S., Busciglio J., Yang X., Hofmann W., Newman W., Mackay C. R., Sodroski J., Gabuzda D.: CCR3 and CCR5 are co-receptors for HIV-1 infection of microglia. Nature, 1997;385:645-649
35. Higuchi H., Hara M., Yamamoto K., Miyamoto T., Kinoshita M., Yamada T., Uchiyama K., Matsumori A.: Mast cells play a critical role in the pathogenesis of viral myocarditis. Circulation, 2008;118:363-372
36. Holt P. G., Sly P. D.: Interactions between RSV infection, asthma, and atopy: unraveling the complexities. J. Exp. Med., 2002;196:1271-1275
37. Hosoda M., Yamaya M., Suzuki T., Yamada N., Kamanaka M., Sekizawa K., Butterfield J. H., Watanabe T., Nishimura H., Sasaki H.: Effects of rhinovirus infection on histamine and cytokine production by cell lines from human mast cells and basophils. J. Immunol., 2002;169:1482-1491
38. Hsu C. L., Neilsen C. V., Bryce P. J.: IL-33 is produced by mast cells and regulates IgE-dependent inflammation. Plos One, 2010;5:e11944
39. Ida S., Siraganian R. P., Notkins A. L.: Cell-bound and circulating IgE antibody to herpes simplex virus. J. Gen. Virol., 1983;64:533-537
40. Ikeda R. K., Miller M., Nayar J., Walker L., Cho J. Y., McElwain K., McElwain S., Raz E., Broide D. H.: Accumulation of peribronchial mast cells in a mouse model of ovalbumin allergen induced chronic airway inflammation: modulation by immunostimulatory DNA sequences. J. Immunol., 2003;171:4860-4867
41. Inomata N., Tomita H., Ikezawa Z., Saito H.: Differential gene expression profile between cord blood progenitor-derived and adult progenitor-derived human mast cells. Immunol. Lett., 2005;98:265-271
42. Jolly S., Detilleux J., Desmecht D.: Extensive mast cell degranulation in bovine respiratory syncytial virus-associated paroxystic respiratory distress syndrome. Vet. Immunol. Immunopathol., 2004;97:125-136
43. Kadowaki N., Liu Y. J.: Natural type I interferon-producing cells as a link between innate and adaptive immunity. Hum. Immunol., 2002;63:1126-1132
44. Kalesnikoff J., Galli S. J.: New developments in mast cell biology. Nat. Immunol., 2008;9:1215-1223
45. King C. A., Anderson R., Marshall J. S.: Dengue virus selectively induces human mast cell chemokine production. J. Virol., 2002;76:8408-8419
46. King C. A., Marshall J. S., Alshurafa H., Anderson R.: Release of vasoactive cytokines by antibody-enhanced dengue virus infection of a human mast cell/basophil line. J. Virol., 2000;74:7146-7150
47. Kloepfer K. M., Gern J. E.: Virus/allergen interactions and exacerbations of asthma. Immunol. Allergy Clin. North Am., 2010;30:553-563
48. Kubo Y., Fukuishi N., Yoshioka M., Kawasoe Y., Iriguchi S., Imajo N., Yasui Y., Matsui N., Akagi M.: Bacterial components regulate the expression of Toll-like receptor 4 on human mast cells. Inflamm. Res., 2007;56:70-75
49. Kulka M., Alexopoulou L., Flavell R. A., Metcalfe D. D.: Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J. Allergy Clin. Immunol., 2004;114:174-182
50. Kulka M., Metcalfe D. D.: TLR3 activation inhibits human mast cell attachment to fibronectin and vitronectin. Mol. Immunol., 2006;43:1579-1586
51. Kurt-Jones E. A., Chan M., Zhou S., Wang J., Reed G., Bronson R., Arnold M. M., Knipe D. M., Finberg R. W.: Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. USA, 2004;101:1315-1320
52. Kurt-Jones E. A., Popova L., Kwinn L., Haynes L. M., Jones L. P., Tripp R. A., Walsh E. E., Freeman M. W., Golenbock D. T., Anderson L. J., Finberg R. W.: Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol., 2000;1:398-401
53. Li Y., Li L., Wadley R., Reddel S. W., Qi J. C., Archis C., Collins A., Clark E., Cooley M., Kouts S., Naif H. M., Alali M., Cunningham A., Wong G. W., Stevens R. L., Krilis S. A.: Mast cells/basophils in the peripheral blood of allergic individuals who are HIV-1 susceptible due to their surface expression of CD4 and the chemokine receptors CCR3, CCR5, and CXCR4. Blood, 2001;97:3484-3490
54. Matsushima H., Yamada N., Matsue H., Shimada S.: TLR3-, TLR7-, and TLR9-mediated production of proinflammatory cytokines and chemokines from murine connective tissue type skin-derived mast cells but not from bone marrow-derived mast cells. J. Immunol., 2004;173:531-541
55. McCurdy J. D., Olynych T. J., Maher L. H., Marshall J. S.: Cutting edge: distinct Toll-like receptor 2 activators selectively induce different classes of mediator production from human mast cells. J. Immunol., 2003;170:1625-1629
56. McLachlan J. B., Abraham S. N.: Studies of the multifaceted mast cell response to bacteria. Curr. Opin. Microbiol., 2001;4:260-266
57. Medzhitov R.: Recognition of microorganisms and activation of the immune response. Nature, 2007;449:819-826
58. Metcalfe D. D., Baram D., Mekori Y. A.: Mast cells. Physiol. Rev., 1997;77:1033-1079
59. Metz M., Grimbaldeston M. A., Nakae S., Piliponsky A. M., Tsai M., Galli S. J.: Mast cells in the promotion and limitation of chronic inflammation. Immunol. Rev., 2007;217:304-328
60. Mokhtarian F., Griffin D. E.: The role of mast cells in virus-induced inflammation in the murine central nervous system. Cell. Immunol., 1984;86:491-500
61. Mrabet-Dahbi S., Metz M., Dudeck A., Zuberbier T., Maurer M.: Murine mast cells secrete a unique profile of cytokines and prostaglandins in response to distinct TLR2 ligands. Exp. Dermatol., 2009;18:437-444
62. Murawski M. R., Bowen G. N., Cerny A. M., Anderson L. J., Haynes L. M., Tripp R. A., Kurt-Jones E. A., Finberg R. W.: Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J. Virol., 2009;83:1492-1500
63. Murray C. S., Simpson A., Custovic A.: Allergens, viruses, and asthma exacerbations. Proc. Am. Thorac. Soc., 2004;1:99-104
64. Nakamura Y., Kambe N., Saito M., Nishikomori R., Kim Y. G., Murakami M., Núñez G., Matsue H.: Mast cells mediate neutrophil recruitment and vascular leakage through the NLRP3 inflammasome in histamine-independent urticaria. J. Exp. Med., 2009;206:1037-1046
65. + T-cell recruitment. Blood, 2005;106:978-987
66. H3 region of IgE. J. Immunol., 2000;164:589-595
67. H3 region of IgE. J. Immunol., 1998;161:5647-5655
68. Qi J. C., Stevens R. L., Wadley R., Collins A., Cooley M., Naif H. M., Nasr N., Cunningham A., Katsoulotos G., Wanigasek Y., Roufogalis B., Krilis S. A.: IL-16 regulation of human mast cells/basophils and their susceptibility to HIV-1. J. Immunol., 2002;168:4127-4134
69. Sato A., Linehan M. M., Iwasaki A.: Dual recognition of herpes simplex viruses by TLR2 and TLR9 in dendritic cells. Proc. Natl. Acad. Sci. USA, 2006;103:17343-17348
70. Shelburne C. P., Abraham S. N.: The mast cell in innate and adaptive immunity. Adv. Exp. Med. Biol., 2011;716:162-185
71. Shirato K., Taguchi F.: Mast cell degranulation is induced by A549 airway epithelial cell infected with respiratory syncytial virus. Virology, 2009;386:88-93
72. Sigurs N.: Epidemiologic and clinical evidence of a respiratory syncytial virus-reactive airway disease link. Am. J. Respir. Crit. Care Med., 2001;163:S2-S6
73. Sorden S. D., Castleman W. L.: Virus-induced increases in airway mast cells in brown Norway rats are associated with enhanced pulmonary viral replication and persisting lymphocytic infiltration. Exp. Lung Res., 1995;21:197-213
74. Sorden S. D., Castleman W. L.: Virus-induced increases in bronchiolar mast cells in Brown Norway rats are associated with both local mast cell proliferation and increases in blood mast cell precursors. Lab. Invest., 1995;73:197-204
75. St. John A. L., Rathore A. P., Yap H., Ng M. L., Metcalfe D. D., Vasudevan S. G., Abraham S. N.: Immune surveillance by mast cells during dengue infection promotes natural killer (NK) and NKT-cell recruitment and viral clearance. Proc. Natl. Acad. Sci. USA, 2011;108:9190-9195
76. Sugiyama K.: Histamine release from rat mast cells induced by Sendai virus. Nature, 1977;270:614-615
77. Sun Q., Wang D., She R., Li W., Liu S., Han D., Wang Y., Ding Y.: Increased mast cell density during the infection with velogenic Newcastle disease virus in chickens. Avian Pathol., 2008;37:579-585
78. Sundstrom J. B., Ellis J. E., Hair G. A., Kirshenbaum A. S., Metcalfe D. D., Yi H., Cardona A. C., Lindsay M. K., Ansari A. A.: Human tissue mast cells are an inducible reservoir of persistent HIV infection. Blood, 2007;109:5293-5300
79. Sundstrom J. B., Hair G. A., Ansari A. A., Secor W. E., Gilfillan A. M., Metcalfe D. D., Kirshenbaum A. S.: IgE-FcεRI interactions determine HIV coreceptor usage and susceptibility to infection during ontogeny of mast cells. J. Immunol., 2009;182:6401-6409
80. Sundstrom J. B., Little D. M., Villinger F., Ellis J. E., Ansari A. A.: Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells. J. Immunol., 2004;172:4391-4401
81. Tachimoto H., Sato S., Yanagihara Y., Ebisawa M.: TLR3 stimulation enhanced FcεRI-mediated MIP-1a production from cultured human mast cells. J. Allergy Clin. Immunol., 2006;2:S66
82. Takeuchi O., Akira S.: Innate immunity to virus infection. Immunol. Rev., 2009;227:75-86
83. Tan W. C.: Viruses in asthma exacerbations. Curr. Opin. Pulm. Med., 2005;11:21-26
84. Taub D. D., Mikovits J. A., Nilsson G., Schaffer E. M., Key M. L., Petrow-Sadowski C., Ruscetti F. W.: Alterations in mast cell function and survival following in vitro infection with human immunodeficiency viruses-1 through CXCR4. Cell. Immunol., 2004;230:65-80
85. Thompson A. J., Locarnini S. A.: Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response. Immunol. Cell Biol., 2007;85:435-445
86. Thompson M. R., Kaminski J. J., Kurt-Jones E. A., Fitzgerald K. A.: Pattern recognition receptors and the innate immune response to viral infection. Viruses, 2011;3:920-940
87. Tsai M., Grimbaldeston M., Galli S. J.: Mast cells and immunoregulation/immunomodulation. Adv. Exp. Med. Biol., 2011;716:186-211
88. Tuchinda M., Dhorranintra B., Tuchinda P.: Histamine content in 24-hour urine in patients with dengue haemorrhagic fever. Southeast Asian J. Trop. Med. Publ. Health, 1977;8:80-83
89. Varadaradjalou S., Féger F., Thieblemont N., Hamouda N. B., Pleau J. M., Dy M., Arock M.: Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur. J. Immunol., 2003;33:899-906
90. Wang D., Liu Y., She R., Xu J., Liu L., Xiong J., Yang Y., Sun Q., Peng K.: Reduced mucosal injury of SPF chickens by mast cell stabilization after infection with very virulent infectious bursal disease virus. Vet. Immunol. Immunopathol., 2009;131:229-237
91. Wang D., Xiong J., She R., Liu L., Zhang Y., Luo D., Li W., Hu Y., Wang Y., Zhang Q., Sun Q.: Mast cell mediated inflammatory response in chickens after infection with very virulent infectious bursal disease virus. Vet. Immunol. Immunopathol., 2008;124:19-28
92. Welliver R. C., Wong D. T., Sun M., Middleton E. Jr, Vaughan R. S., Ogra P. L.: The development of respiratory syncytial virus-specific IgE and the release of histamine in nasopharyngeal secretions after infection. N. Engl. J. Med., 1981;305:841-846
93. Yamamoto K., Kawamura I., Ito J., Mitsuyama M.: Modification of allergic inflammation in murine model of rhinitis by different bacterial ligands: involvement of mast cells and dendritic cells. Clin. Exp. Allergy, 2006;36:760-769
94. Yang H., Wei J., Zhang H., Lin L., Zhang W., He S.: Upregulation of Toll-like receptor (TLR) expression and release of cytokines from P815 mast cells by GM-CSF. BMC Cell. Biol., 2009;10:37
95. Yoshioka M., Fukuishi N., Iriguchi S., Ohsaki K., Yamanobe H., Inukai A., Kurihara D., Imajo N., Yasui Y., Matsui N., Tsujita T., Ishii A., Seya T., Takahama M., Akagi M.: Lipoteichoic acid downregulates FcεRI expression on human mast cells through Toll-like receptor 2. J. Allergy Clin. Immunol., 2007;120:452-461
96. Yoshioka M., Fukuishi N., Kubo Y., Yamanobe H., Ohsaki K., Kawasoe Y., Murata M., Ishizumi A., Nishii Y., Matsui N., Akagi M.: Human cathelicidin CAP18/LL-37 changes mast cell function toward innate immunity. Biol. Pharm. Bull., 2008;31:212-226
97. Yu M., Levine S. J.: Toll-like receptor, RIG-I-like receptors and the NLRP3 inflammasome: key modulators of innate immune responses to double-stranded RNA viruses. Cytokine Growth Factor Rev., 2011;22:63-72
98. Zhu F. G., Marshall J. S.: CpG-containing oligodeoxynucleotides induce TNF-α and IL-6 production but not degranulation from murine bone marrow-derived mast cells. J. Leukoc. Biol., 2001;69:253-262